Turning agencies' blues into children's cheer

Share this article:
Hard to Swallow celebrated their Pharmapalooza win
Hard to Swallow celebrated their Pharmapalooza win

AbelsonTaylor delivered a perfect pitch of a different kind last night when the agency's in-house ensemble, Hard to Swallow, scooped up first prize at the industry's annual battle of the bands contest.

Pharmapalooza 6, organized by The CDM Group, attracted hundreds of healthcare marketers to BB King Blues and Bar in New York's Times Square for a charitable evening of live music, comedy, food, drink and great company. 

And while AbelsonTaylor will no doubt enjoy taking a year's worth of musical bragging rights back to Chicago, the real winner was The Children's Hospital at Montefiore (CHAM), for whom the event raised more than $80,000. This brings the total raised by the six Pharmapalooza events to in excess of $575,000.

Second place in last night's contest was CDMi's Urge to Merge, while ghg's Pharma's Daughter finished third. Also competing for the trophy were CDM Princeton's The Jughandles and Publicis Kaplan Thaler's Hot Flash.

Judging the contest were four music industry legends: J.P. Evangelista, senior director of music programming, industry relations and sales strategy, VEVO;  Bryan Grone, label relations, Spotify; Jack McMorrow, SVP, Atlantic Records; and Jason Spiewak, president and founder, JLS Artist Management and Noble Steed Music.

You can see more of the action at the Pharmapalooza 6 Facebook page.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.